Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.
about
Yttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaYttrium-90 microsphere radioembolisation for unresectable hepatocellular carcinomaCurrent Status of Hepatic Arterial Infusion ChemotherapyThe role of interventional radiology in the management of hepatocellular carcinomaTreatment of hepatocellular carcinoma with major portal vein thrombosis by combined therapy with subcutaneous interferon-α and intra-arterial 5-fluorouracil; role of type 1 interferon receptor expressionStaging of hepatocellular carcinomaManagement strategies for hepatocellular carcinoma: old certainties and new realities.Tumor and liver determinants of prognosis in unresectable hepatocellular carcinoma: a large case cohort study.Reassessing hepatocellular carcinoma staging in a changing patient population.Staging of biliary tract and primary liver tumors.Twenty-four hour intra-arterial infusion of 5-fluorouracil, cisplatin, and leucovorin is more effective than 6-hour infusion for advanced hepatocellular carcinoma.Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.Prognosis of patients with hepatocellular carcinoma. Validation and ranking of established staging-systems in a large western HCC-cohort.Cisplatin-Based Combination Chemotherapy for Advanced Hepatocellular Carcinoma: A Single Center Experience before the Sorafenib Era.V-CLIP: Integrating plasma vascular endothelial growth factor into a new scoring system to stratify patients with advanced hepatocellular carcinoma for clinical trials.Combination trans arterial chemoembolization (TACE) plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review of the literature.Comparing staging systems for predicting prognosis and survival in patients with hepatocellular carcinoma in Egypt.Proactive case finding to improve concurrently curative and palliative care in patients with end-stage liver disease.I-CLIP: improved stratification of advanced hepatocellular carcinoma patients by integrating plasma IGF-1 into CLIP score.Evaluation of the new AJCC staging system for resectable hepatocellular carcinomaLevel of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinomaPrognostic factors for survival in patients with early-intermediate hepatocellular carcinoma undergoing non-surgical therapy: comparison of Okuda, CLIP, and BCLC staging systems in a single Italian centre.The microRNA-325 inhibits hepatocellular carcinoma progression by targeting high mobility group box 1.Staging classifications for hepatocellular carcinoma.Impact of cytolysis following transarterial chemoembolization for hepatocellular carcinomaComparison of five staging systems in hepatocellular carcinoma treated with sorafenib: A single-center experienceSurgical treatment for liver cancer. Current issues.Review of current staging systems for hepatocellular carcinoma.Clinical outcome in patients with hepatocellular carcinoma after living-donor liver transplantation.High-dose hypofractionated X-ray radiotherapy for hepatocellular carcinoma: Tumor responses and toxicitiesComparative study of staging systems for hepatocellular carcinoma in 428 patients treated with radioembolization.Adaptive immunity in hepatocellular carcinoma: prognostic and therapeutic implications.Staging systems: Is there a surgical staging and a medical one? A surgeon's perspective.Regulatory T cells in HBV and HCV liver diseases: implication of regulatory T lymphocytes in the control of immune response.Hepatocellular carcinoma: MR staging and therapeutic decisions.What is the best staging system for hepatocellular carcinoma in the setting of liver transplantation?Toxicity and efficacy of hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma (Review).Staging systems of hepatocellular carcinoma: a review of literature.Staging systems for hepatocellular carcinoma: Current status and future perspectivesOverview of Staging Systems for Hepatocellular Carcinoma and Implications for Interventional Radiology.
P2860
Q24186130-56B35EC9-7CA3-41FC-B668-35CDF2FAB294Q24194017-25032993-75D5-4CE7-9EF3-F39208886120Q26775437-B088783D-85FC-4404-AFAF-6A56AE528482Q26996805-74BDCD6E-7DA2-41F0-8BFE-A983EEAF14BBQ27485914-EF34DC08-06FF-45C4-A67E-D59657A94F11Q28081265-9BC981C9-E82A-4BF7-9A4C-91E3C85BE75BQ30252143-7380ADEE-8752-4A1D-A143-691117A1F715Q33718951-4E537E4E-F6A3-4A97-BEE9-03F3D1087BB7Q33767286-E71E1174-3A00-4602-874B-36B7B6BE1D02Q33773415-72ACA379-BF5C-4BFA-B6A0-137152FA179DQ33787850-E8081EC5-FB0E-4F16-9B79-5166A741B5DEQ34155198-E03EA80D-0511-4546-BB81-F514CB6C38E3Q34446810-9D83DC75-5494-44AC-8A64-C2E38ADDD8E3Q34494749-A0C16D2F-84A7-457D-802A-A99864E692D2Q34733478-3D460FBD-18C4-4494-BBA5-880D33E516BAQ34991643-F5323D0C-FCE0-41E6-85DE-54E3E21FC914Q35113002-AA7444CB-B708-41C6-A989-007194725B8FQ35200244-0734E681-89A6-4DAE-873B-3B476A0509A0Q35208826-3BA482A1-EEF7-44AA-B835-7678DA29C65FQ35431693-00BB805C-4DB9-499A-ADD2-AB4D22E38E43Q35435112-A9F06DBF-18E2-46DC-8A75-BB588B40E7ABQ35597241-BAC49BF7-A9E2-4BD3-B797-A1C6AECD9AAEQ35875277-A863D987-23EA-4139-A7AE-A68ABB98F57FQ36150362-FC3E394F-D507-4D51-80E8-1FDDC2A31E1FQ36582556-FB25A722-58ED-42DD-A96B-71A32449BDDFQ36741673-34780F5B-00EC-47EA-B7D7-FA2D94AEF113Q36796770-2A858137-A1D0-47DA-97E0-47CFE05AA7E8Q36945069-7689B033-1BB2-4438-A541-1423AE366E76Q37068256-3B603452-B8B0-4EC4-889F-2DE65361CFA0Q37269624-C95185E7-26A7-4C73-9AE8-FB9288EEC679Q37396794-901EB839-52FE-4A48-98DF-8E121DC33097Q37614595-BF7D5DCC-DE01-4F36-BC5C-FE8CCDAC725BQ37625925-038D6C00-4564-4E83-9850-6BDA6D8658F0Q37798839-D08E5CDC-AB26-4466-AAAE-BE835511FEAAQ37863539-24A3AA40-9756-4B2E-88BB-9D7AC9E6FC62Q37886890-3F2BEEA3-2024-4174-81D7-DBF0B650CCAAQ38022245-0DE2D33E-E9BF-4927-B0CA-5B361D9F917EQ38207014-A29533AB-C012-4E98-8FC4-CFBC29A96712Q38408876-9EA1318C-C211-420D-B5D7-2C034BBF9846Q39349696-E346C802-CB38-486F-9A0F-BE3D08FD7AA0
P2860
Staging of hepatocellular carcinoma: assessment of the CLIP, Okuda, and Child-Pugh staging systems in a cohort of 257 patients in Toronto.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@ast
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@en
type
label
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@ast
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@en
prefLabel
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@ast
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@en
P2093
P2860
P356
P1433
P1476
Staging of hepatocellular carc ...... rt of 257 patients in Toronto.
@en
P2093
Liver Cancer Study Group of the University of Toronto
P2860
P304
P356
10.1136/GUT.50.6.881
P407
P577
2002-06-01T00:00:00Z